BioCentury
ARTICLE | Clinical News

Epoetin zeta: Phase I started

August 2, 2010 7:00 AM UTC

Hospira began a single-blind, crossover, U.S. Phase I trial in 100 patients to compare IV epoetin zeta vs. Epogen epoetin alfa from Amgen Inc. (NASDAQ:AMGN, Thousand Oaks, Calif.). Retacrit epoetin...